Use of resources, quality of life, and clinical outcomes in patients with and without new Q waves after thrombolytic therapy for acute myocardial infarction (from the GUSTO-I trial)

American Journal of Cardiology

Volumn 86, Issue 1, 2000, Pages 24-29

  Barbagelata, Alejandro ^e   Califf, Robert M ^a   Sgarbossa, Elena B ^b   Goodman, Shaun G ^c   Knight, David ^a   Mark, Daniel B ^a   Granger, Christopher B ^a   Agranatti, Daniel A ^e   Mautner, Branco ^e   Ohman, E Magnus ^a   Suárez, Luis D ^e   Armstrong, Paul W ^d   Gates, Kathy ^a   Wagner, Galen S ^a  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d UNIVERSITY OF ALBERTA   (Canada)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE HEART INFARCTION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; ELECTROCARDIOGRAM; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; Q WAVE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL;

AGED; CORONARY ANGIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FIBRINOLYTIC AGENTS; HEALTH STATUS; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT READMISSION; PROGNOSIS; QUALITY OF LIFE; RECURRENCE; STREPTOKINASE; SURVIVAL RATE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0034237573     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(00)00823-7     Document Type: Article

References (25)

1. Boden W.E. Electrocardiographic correlates of reperfusion status after thrombolysis is the incomplete or interrupted infarction a non-Q-wave infarction? Am J Cardiol. 68:1991;520-524.
2. Barbagelata A., Califf R.M., Sgarbossa E., Goodman S.G., Stebbins A.L., Granger C.B., Suarez L.D., Borruel M., Gates K., Starr S., Wagner G.S. Thrombolysis and Q-wave versus non-Q-wave first acute myocardial infarction GUSTO-I substudy . J Am Coll Cardiol. 29:1997;771-777.
3. Langer A., Goodman S.G., Topol E.J., Charlesworth A., Skene A.M., Wilcox R.G., Armstrong P.W. Late assessment of thrombolytic efficacy (LATE) study prognosis in patients with non-Q-wave myocardial infarction . J Am Coll Cardiol. 27:1996;1327-1332.
4. Goodman S.G., Langer A., Ross A.M., Wildermann N.M., Barbagelata A., Sgarbossa E.B., Wagner G.S., Granger C.B., Califf R.M., Topol E.J., Simoons M.L., Armstrong P.W. Non-Q vs. Q-wave myocardial infarction after thrombolytic therapy angiographic and prognostic insights from the GUSTO-I angiographic substudy . Circulation. 97:1998;444-450.
5. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med. 329:1993;673-682.
6. Mark D.B., Naylor C.D., Hlatky M.A., Califf R.M., Topol E.J., Granger C.B., Knight J.D., Nelson C.L., Lee K.L., Clapp-Channing N.E. Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States. N Engl J Med. 331:1994;1130-1135.
7. Mark D.B. Quality of life assessment. Califf R.M., Mark D.B., Wagner G.S. Acute Coronary Care. 2nd ed. 1995;183-199 Mosby Year Book, Chicago.
8. Hlatky M.A., Boineau R.E., Higginbotham M.B., Lee K.L., Mark D.B., Califf R.M., Cobb F.R., Pryor D.B. A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). Am J Cardiol. 64:1989;651-654.
9. Katz S., Downs T.D., Cash H.R., Grotz R.C. Progress in development of the index of ADL. Gerontologist. 10:1970;20-30.
10. National Center for Heath Statistics. Hyattsville, MD: Public Health Service; 1992. (DHHS publication no. (PHS) 92-1232).
11. The BARI Investigators. Protocol for the Bypass Angioplasty Revascularization Investigation. Circulation 1991;84(suppl V):V-1-V-27.
12. Koenig H.G., Cohen H.J., Blazer D.G., Meador K.G., Westlund R. A brief depression scale for use in the medically ill. Int J Psych Med. 22:1992;183-195.
13. Torrance G.W. Utility approach to measuring health-related quality of life. J Chronic Dis. 40:1987;593-600.
14. Tsevat J., Dawson N.V., Matchar D.B. Assessing quality of life and preferences in seriously ill using utility theory. J Clin Epidemiol. 43:(suppl):1990;73S-77S.
15. Aguirre F.V., Younis L.T., Chaitman B.R., Ross A.M., McMahon R.P., Kern M.J., Berger P.B., Sopko G., Rogers W.J., Shaw L. Early and 1-year clinical outcome of patients' evolving non-Q-wave versus Q-wave myocardial infarction after thrombolysis results from the TIMI II study . Circulation. 91:1995;2541-2548.
16. Boden W.E., Roberts R. Prognosis and management of patients with non-Q-wave myocardial infarction. Prog Cardiol. 4:1991;143-160.
17. The effect of dialtiazem on mortality and reinfarction after myocardial infarction. N Engl J Med. 319:1988;385-392.
18. Verapamil in acute myocardial infarction. Eur Heart J. 5:1984;516-528.
19. Yusuf S, Sleight P, Held P, McMahon S. Routine medical management of acute myocardial infarction. Lessons from overviews of recent randomized controlled trials. Circulation 1990;82(suppl III):III-117-III-134.
20. Furberg C.D., Psaty B.M., Meyer J.V. Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. Circulation. 92:1995;1326-1331.
21. Held P.H., Yusuf S., Furberg C.D. Calcium channel blockers in acute myocardial infarction and unstable angina an overview . Br Med J. 299:1989;1187-1192.
22. Yusuf S., Held P.H., Furberg C.D. Update of effects of calcium antagonist in myocardial infarction or angina in light of the second Danish Verapamil Infarction Trial (DAVIT-II) and other recent studies. Am J Cardiol. 67:1991;1295-1297.
23. Held P.H., Yusuf S. Impact of calcium channel blockers on mortality in survivors of acute myocardial infarction. Singh B.N., Wellens H.J.J., Hiraoka M. Electropharmacological Control of cardiac arrythmias. 1994;399-411 Futura Publishing, Mount Kisco, NY.
24. Held P.H., Yusuf S. Calcium antagonists in the treatment of ischemic heart disease myocardial infarction . Coron Artery Dis. 5:1994;21-26.
25. Gibson R.S., Boden W.E. Calcium channel antagonists friend or foe on post-infarction patients? Am J Hypertens. 9:1996;172S-176S.